Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers. He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Jingang Medicine (Aus) Pty Ltd, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He was the inaugural president of the Australian Academy of Health and Medical Sciences, and a member of the Australian National Science and Technology Council. He chairs the Australian Medical Research Advisory Board of the Medical Research Future Fund.
He was recognised as Australian of the Year in 2006. He was recipient of the Prime Ministers Prize for Science, and of the Balzan Prize, in 2008, and was elected Fellow of the Royal Society of London in 2012. He was appointed Companion of the Order of Australia in the Queen’s Birthday Honours list in 2013.
Immunity, Autoimmune disease, Genital wart virus disease, Immunodeficiency, Papillomavirus vaccines, Transplantation immunology, Tumour immunology, Viral infection, Viral vaccines, Immunology, Medical education, Pathology, Cancer - vaccines to prevent, Cervical cancer vaccine, Allergy, Education - medical, Host-virus interactions, Viruses, Vaccines, Tumour vaccines, Cancer - immunity, Warts - genital